Many DexCom, Inc. (NASDAQ:DXCM) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. Knowing whether insiders are buying is usually more helpful ...

Dexcom, a glucose-monitoring company based in San Diego, is laying off 350 employees. The company announced Wednesday that it was cutting 3% of its global workforce. Of the 350 laid off, 196 workers ...

11 analysts have expressed a variety of opinions on DexCom DXCM over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table below ...

DexCom, Inc. focuses on the design, development, and commercialization of CGM systems in the United States and internationally to support the management of diabetes and metabolic health by patients, ...

Dexcom, the San Diego-based maker of continuous glucose monitors for diabetes patients and prediabetics, announced Wednesday that it is laying off around 350 workers, or 3% of its global workforce.

Dexcom, a San Diego biotech company known for its continuous glucose monitoring systems, is laying off a few hundred workers as it moves its operations and manufacturing from California to Arizona.

The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate ...

Shares of DexCom Inc. DXCM advanced 6.22% to $78.92 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.51% to 6,448.26 and ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 3.3% in the afternoon session after company executives provided an optimistic outlook at the Wells Fargo Healthcare Conference on Wednesday ...

A new continuous glucose monitoring approach is making its debut over-the-counter—one that’s aimed not specifically at people with diabetes, but at users looking to guide their weight loss with ...